On Thursday, Shares of Inotek Pharmaceuticals Corporation (NASDAQ:ITEK), skyrocketed 193.88% to $15.37, hitting its highest level.
Inotek Pharmaceuticals Corporation declared the Phase 3 development strategy of its lead glaucoma drug, trabodenoson, a first-in-class selective adenosine mimetic designed to restore the eye’s natural pressure control mechanism. Based on feedback from a recent End of Phase 2 meeting with the US Food and Drug Administration (FDA), Inotek is in final preparation stages to commence its first Phase 3 trial to support a New Drug Application (NDA) for trabodenoson.
The trial design for the first pivotal study is a five-arm superiority trial that will comprise three doses of trabodenoson. These doses were selected to optimize lowering of intraocular pressure while maintaining the good tolerability observed in Phase 2 trials. The primary efficacy endpoint of the study is the reduction of intraocular pressure (IOP), statistically superior as contrast to placebo. A comparator arm of timolol will also be comprised of for study validation, but not for statistical comparison.
Inotek Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for glaucoma.
Shares of Discover Financial Services (NYSE:DFS), declined -3.80% to $57.24, during its last trading session.
Discover Financial Services has been recognized as a recipient of four Best Asian Pacific American (APA) Employer Awards. Presented by the Asia Society, the awards honor companies that support and develop APA employees.
Discover received the following 2015 citations for Best Practices in Retention, Diversity, and Asian-Pacific American Employee Resource Group. Discover received Noteworthy Performance Recognition as Best Employer for Asian Pacific American Employee Resource Groups.
Recognition is based on results from the 2015 APA Corporate Survey, which highlight outstanding companies that have successful best practices models for leadership, development and the advancement of APA employees.
Discover Financial Services operates as a direct banking and payment services company in the United States. It operates in two segments, Direct Banking and Payment Services.
Finally, CME Group Inc. (NASDAQ:CME), ended its last trade with -2.34% loss, and closed at $96.62.
CME Group and Multi Commodity Exchange of India Limited (MCX), India’s leading commodity exchange, signed a Memorandum of Understanding (MOU) on various cooperation activities and potential business opportunities, counting a joint viability study of setting up operations in an International Finance Service Center in India.
Under this MOU, various initiatives between CME Group and MCX will also comprise the establishment of a joint working group to explore opportunities to develop and market new products and services for the US and Indian markets, in addition to partnership on customer education.
At the same time, CME Group and MCX also declared the extension of the licensing agreement, which enables MCX to settle their rupee-denominated oil and gas contract to CME Group’s NYMEX prices.
“We are happy to sign an MOU to explore opportunities and cooperate on product development and market education, and at the same time, extending the licensing agreement with MCX,” said Derek Sammann, Senior Managing Director, Global Head of Commodities & Options Products, CME Group. “We look forward to working more closely with MCX in internationalizing its commodity markets and providing international market participants greater access to markets in India.”
CME Group Inc., through its auxiliaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products for trading and/or clearing across various asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
